Pathogenic BRCA1 and BRCA2 germline variants confer an increased risk of hereditary breast and ovarian cancer (HBOC). In this high-risk cohort, novel biomarkers are needed to support patient management. While circulating cell-free DNA-based conventional CpG-level averaging is promising, it dilutes tumor-specific signal...
Aishwarya Sekar, J. Broche, Veronika Buršić et al.· npj Breast Cancer· 0 citations
Functional experiments demonstrate that LMO7 silencing decreases clonogenicity and migratory capacity in vitro and suppresses primary tumor growth and metastatic dissemination in vivo, and illustrate how integrating functional, spatial and clinical data can uncover oncogene-driven effectors of metastasis.
Veronika Buršić, Heng Luo, C. Hénon et al.· bioRxiv· 0 citations
Metastatic dissemination represents the major determinant of poor clinical outcome across cancer entities. Yet, how driver oncogenes shape transcriptional programs facilitating metastasis is poorly understood. In Ewing sarcoma (EwS) – a highly aggressive pediatric bone and soft-tissue sarcoma driven by chimeric FET::ET...
Veronika Buršić, Heng Luo, C. Hénon et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.